@niko @Fran911@nobigtech.es El origenhttps://esclerosismultiple.com/europa-aprueba-ofatumumab-para-formas-recurrentes-de-esclerosis-multiple/
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.
